Projects

PRESCRIPTEC - Prevention and Screening Innovation Project Toward Elimination of Cervical Cancer (HORIZON 2020), funded by DBT

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2020 - 2025

Project Lead

Authors

Dr. Premalatha T. S, Dr. Kiran Abhijit Kulkarni, Dr. Geeta Acharya Dr Vishakha C. Bidkar

Project Status

completed